This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: ETH Zurich, Unversität Zürich. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016
Title: Inge K Herrmann: Innovator in Medical Formulations
Introduction
Inge K Herrmann is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical formulations, particularly in the treatment of inflammatory reactions and ischemia-reperfusion events. His innovative work has the potential to improve patient outcomes in critical medical conditions.
Latest Patents
Inge K Herrmann holds a patent for an injectable formulation designed for the treatment and protection of patients experiencing inflammatory reactions or ischemia-reperfusion events. The patent describes compounds suitable for addressing medical conditions involving hypoxic, anoxic, and inflamed mammalian tissue. The invention also encompasses the preparation of medicaments and pharmaceutical preparations that include these compounds. Furthermore, it outlines methods for treating or protecting patients prone to develop such medical conditions through the administration of therapeutically effective amounts of the compounds.
Career Highlights
Throughout his career, Inge K Herrmann has been associated with prestigious institutions such as Universität Zürich and ETH Zurich. His work at these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Inge K Herrmann has worked alongside notable colleagues, including Beatrice Beck-Schimmer and Wendelin Jan Stark. These collaborations have enriched his research and expanded the impact of his innovations in medical science.
Conclusion
Inge K Herrmann's contributions to medical formulations highlight the importance of innovation in healthcare. His patent for an injectable formulation represents a significant advancement in treating critical medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile